Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Effect of matcha green tea on cognitive functions and sleep quality in older adults with cognitive decline: A randomized controlled study over 12 months. Local targets link to admitted publications; unresolved targets remain external evidence.
World Alzheimer Report 2022: Life after diagnosis: Navigating treatment, care and support.
2022 · External reference
World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia.
10.1002/alz.12123 · 2020 · External reference
A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.
10.1016/s0140-6736(15)60461-5 · 2015 · External reference
Association of the Mediterranean Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet with the risk of dementia.
2023 · External reference
Accelerometer-determined physical activity and cognitive function in middle-aged and older adults from two generations of the Framingham Heart Study
2019 · External reference
Effects of daily matcha and caffeine intake on mild acute psychological stress-related cognitive function in middle-aged and older adults: A Randomized Placebo-Controlled Study.
2021 · External reference
Matcha consumption maintains attentional function following a mild acute psychological stress without affecting a feeling of fatigue: A randomized placebo-controlled study in young adults.
10.1016/j.nutres.2020.12.024 · 2021 · External reference
The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, double-blind, placebo-controlled clinical trial.
2011 · External reference
Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.
10.1016/j.brainres.2008.02.107 · 2008 · External reference
Anti-stress effects of drinking green tea with lowered caffeine and enriched theanine, epigallocatechin and arginine on psychosocial stress induced adrenal hypertrophy in mice.
10.1016/j.phymed.2016.07.006 · 2016 · External reference
Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project
10.1093/ajcn/83.2.355 · 2006 · External reference
Total phenol, catechin, and caffeine contents of teas commonly consumed in the United kingdom
10.1021/jf010153l · 2002 · External reference
Effects of matcha green tea powder on cognitive functions of community-dwelling elderly individuals.
2020 · External reference
Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population.
10.2188/jea.10.79 · 2000 · External reference
An epidemiological study of insomnia among the Japanese general population.
2000 · External reference
Unresolved reference
2006 · External reference
β-Amyloid accumulation in the human brain after one night of sleep deprivation
10.1073/pnas.1721694115 · 2018 · External reference
Implications of sleep disturbance and inflammation for Alzheimer’s disease dementia
10.1016/s1474-4422(18)30450-2 · 2019 · External reference
Association of sleep duration in middle and old age with incidence of dementia.
10.1038/s41467-021-22354-2 · 2021 · External reference
Prediction of longitudinal cognitive decline in preclinical Alzheimer Disease using plasma biomarkers
2023 · External reference
Alpha-2 macroglobulin in Alzheimer’s disease: a marker of neuronal injury through the RCAN1 pathway
10.1038/mp.2016.206 · 2017 · External reference
Association between serum concentrations of apolipoprotein A-I (apoA-I) and Alzheimer’s disease: Systematic Review and Meta-Analysis.
10.3390/diagnostics11060984 · 2021 · External reference
An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer’s disease—A cohort study of 95,442 individuals.
10.1016/j.jalz.2018.07.223 · 2018 · External reference
Plasma transthyretin as a candidate marker for Alzheimer’s disease
10.3233/jad-2011-110611 · 2012 · External reference
Plasma transthyretin as a predictor of amnestic mild cognitive impairment conversion to dementia.
10.1038/s41598-019-55318-0 · 2019 · External reference
Serum albumin concentration and cognitive impairment.
10.2174/156720510790274392 · 2010 · External reference
Amyloid-β sequester proteins as blood-based biomarkers of cognitive decline
10.1016/j.dadm.2015.04.003 · 2015 · External reference
Serum levels of proteins involved in amyloid-β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment
2019 · External reference
Effectiveness of nonpharmacological approaches in patients with mild cognitive impairment.
10.1159/000320575 · 2011 · External reference
The effects of an aerobic and resistance exercise training program on cognition following stroke
10.1177/1545968312465192 · 2013 · External reference
The effectiveness of a cognitive training program in people with mild cognitive impairment: A study in urban community.
10.1016/j.ajp.2018.04.028 · 2018 · External reference
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
10.1016/s0140-6736(20)30367-6 · 2020 · External reference
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
10.2307/2529712 · 1975 · External reference
Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis.
10.1111/acps.12336 · 2014 · External reference
Subjective cognitive decline: Level of risk for future dementia and mild cognitive impairment, a meta-analysis of longitudinal studies.
10.1007/s11065-021-09522-3 · 2022 · External reference
Implementation of subjective cognitive decline criteria in research studies.
10.1016/j.jalz.2016.09.012 · 2017 · External reference
Clinical usefulness of CNS vital signs for assessing neurocognition in ADHD.
2007 · External reference
Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs.
10.1016/j.acn.2006.05.007 · 2006 · External reference
An inventory to assess activities of daily living for clinical trials in Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study
1997 · External reference
ADCS prevention instrument project: Assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials.
10.1097/01.wad.0000213873.25053.2b · 2006 · External reference
Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects.
10.1016/s0165-1781(00)00232-8 · 2000 · External reference
Automatic voxel-based morphometry of structural MRI by SPM8 plus diffeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer Disease.
10.3174/ajnr.a2935 · 2012 · External reference
Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography
2007 · External reference
Effects of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults: A randomized controlled trial.
2019 · External reference
Effect of L-theanine on glutamatergic function in patients with schizophrenia.
10.1017/neu.2015.22 · 2015 · External reference
Connections between sleep and cognition in older adults
10.1016/s1474-4422(14)70172-3 · 2014 · External reference
Self-relaxation training can improve sleep quality and cognitive functions in the older: a one-year randomised controlled trial.
10.1111/jocn.12096 · 2013 · External reference
Short or long sleep duration is associated with memory impairment in older Chinese: the Guangzhou Biobank Cohort Study.
10.1093/sleep/34.5.575 · 2011 · External reference
Sleep quality improvement enhances neuropsychological recovery and reduces blood Aβ42/40 ratio in patients with mild–moderate cognitive impairment.
10.3390/medicina57121366 · 2021 · External reference
Facial emotion recognition in patients with subjective cognitive decline and mild cognitive impairment.
10.1017/s1041610215001520 · 2016 · External reference
Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects.
10.1097/jgp.0b013e318186bd53 · 2008 · External reference
The level of cognitive function and recognition of emotions in older adults.
10.1371/journal.pone.0185513 · 2017 · External reference